{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T17:08:25Z","timestamp":1723914505701},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,8]]},"DOI":"10.7759\/cureus.38742","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T03:28:07Z","timestamp":1683602887000},"source":"Crossref","is-referenced-by-count":2,"title":["Prospective Efficacy and Safety Study of an Innovative Kerascalp Hair Growth Serum in Mild-to-Moderate Alopecia in India: Regrowth Study"],"prefix":"10.7759","author":[{"given":"Malavika","family":"Kohli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Ganjoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aseem","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetan Y","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simran","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagirath","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.15406\/jdc.2021.05.00190","article-title":"Alopecia types, current and future treatment","volume":"5","author":"Rambwawasvika H","year":"2021","unstructured":"Rambwawasvika H, Dzomba P, Gwatidzo L. Alopecia types, current and future treatment. J Dermat Cosmetol. 2021, 5:93-9. 10.15406\/jdc.2021.05.00190","journal-title":"J Dermat Cosmetol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14624","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version","volume":"32","author":"Kanti V","year":"2018","unstructured":"Kanti V, Messenger A, Dobos G, et al.. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol. 2018, 32:11-22. 10.1111\/jdv.14624","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12168.x","article-title":"Androgenetic alopecia in women","volume":"8","author":"Price VH","year":"2003","unstructured":"Price VH. Androgenetic alopecia in women. J Investig Dermatol Symp Proc. 2003, 8:24-7. 10.1046\/j.1523-1747.2003.12168.x","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1501893","article-title":"Effectiveness and safety of botulinum toxin type A in the treatment of androgenetic alopecia","volume":"2020","author":"Zhou Y","year":"2020","unstructured":"Zhou Y, Yu S, Zhao J, Feng X, Zhang M, Zhao Z. Effectiveness and safety of botulinum toxin type A in the treatment of androgenetic alopecia. Biomed Res Int. 2020, 2020:10.1155\/2020\/1501893","journal-title":"Biomed Res Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908123410706","article-title":"The biology of hair follicles","volume":"341","author":"Paus R","year":"1999","unstructured":"Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med. 1999, 341:491-7. 10.1056\/NEJM199908123410706","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000051723","article-title":"Teloptosis, a turning point in hair shedding biorhythms","volume":"203","author":"Pi\u00e9rard-Franchimont C","year":"2001","unstructured":"Pi\u00e9rard-Franchimont C, Pi\u00e9rard GE. Teloptosis, a turning point in hair shedding biorhythms. Dermatology. 2001, 203:115-7. 10.1159\/000051723","journal-title":"Dermatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7753.58556","article-title":"Male androgenetic alopecia: population-based study in 1,005 subjects","volume":"1","author":"Krupa Shankar D","year":"2009","unstructured":"Krupa Shankar D, Chakravarthi M, Shilpakar R. Male androgenetic alopecia: population-based study in 1,005 subjects. Int J Trichology. 2009, 1:131-3. 10.4103\/0974-7753.58556","journal-title":"Int J Trichology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06442.x","article-title":"A study of patterns of androgenetic alopecia in men: an Indian perspective","volume":"152","author":"Grover S","year":"2005","unstructured":"Grover S. A study of patterns of androgenetic alopecia in men: an Indian perspective. Br J Dermatol. 2005, 152:572-4. 10.1111\/j.1365-2133.2005.06442.x","journal-title":"Br J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01920.x","article-title":"Male pattern androgenetic alopecia in an Indian context: a perspective study","volume":"21","author":"Sehgal VN","year":"2007","unstructured":"Sehgal VN, Kak R, Aggarwal A, Srivastava G, Rajput P. Male pattern androgenetic alopecia in an Indian context: a perspective study. J Eur Acad Dermatol Venereol. 2007, 21:473-9. 10.1111\/j.1468-3083.2006.01920.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref10","article-title":"Androgenic alopecia in women: an Indian perspective","volume":"11","author":"Sehgal VN","year":"2013","unstructured":"Sehgal VN, Srivastava G, Aggarwal A, Midha R. Androgenic alopecia in women: an Indian perspective. Skinmed. 2013, 11:332-40.","journal-title":"Skinmed"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20175241","article-title":"Frequency, severity and related factors of androgenetic alopecia in dermatology outpatient clinic: hospital-based cross-sectional study in Turkey","volume":"92","author":"Salman KE","year":"2017","unstructured":"Salman KE, Altunay IK, Kucukunal NA, Cerman AA. Frequency, severity and related factors of androgenetic alopecia in dermatology outpatient clinic: hospital-based cross-sectional study in Turkey. An Bras Dermatol. 2017, 92:35-40. 10.1590\/abd1806-4841.20175241","journal-title":"An Bras Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/ijt.ijt_24_19","article-title":"Expert consensus on the management of androgenetic alopecia in India","volume":"11","author":"Mysore V","year":"2019","unstructured":"Mysore V, Parthasaradhi A, Kharkar RD, et al.. Expert consensus on the management of androgenetic alopecia in India. Int J Trichology. 2019, 11:101-6. 10.4103\/ijt.ijt_24_19","journal-title":"Int J Trichology"},{"key":"ref13","article-title":"Alopecia: herbal remedies","volume":"2","author":"Kaushik R","year":"2011","unstructured":"Kaushik R, Gupta D, Yadav R. Alopecia: herbal remedies. Int J Pharma Sci Res. 2011, 2:1631-7.","journal-title":"Int J Pharma Sci Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S49337","article-title":"Female pattern alopecia: current perspectives","volume":"5","author":"Levy LL","year":"2013","unstructured":"Levy LL, Emer JJ. Female pattern alopecia: current perspectives. Int J Womens Health. 2013, 5:541-56. 10.2147\/IJWH.S49337","journal-title":"Int J Womens Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.116730","article-title":"Androgenetic alopecia: an update","volume":"79","author":"Kaliyadan F","year":"2013","unstructured":"Kaliyadan F, Nambiar A, Vijayaraghavan S. Androgenetic alopecia: an update. Indian J Dermatol Venereol Leprol. 2013, 79:613-25. 10.4103\/0378-6323.116730","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref16","article-title":"Effectiveness of a multi-component lotion in the control of hair loss","volume":"18","author":"Maramaldi G","year":"2016","unstructured":"Maramaldi G, Giacomelli L, Meneghin M, Eggenhoffner R, Togni S. Effectiveness of a multi-component lotion in the control of hair loss. Esper Dermatol. 2016, 18:70-5.","journal-title":"Esper Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0960-0760(02)00187-5","article-title":"Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon","volume":"82","author":"Raynaud JP","year":"2002","unstructured":"Raynaud JP, Cousse H, Martin P. Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon. J Steroid Biochem Mol Biol. 2002, 82:233-9. 10.1016\/s0960-0760(02)00187-5","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2018.1497562","article-title":"Health effects of coconut oil - a narrative review of current evidence","volume":"38","author":"Wallace TC","year":"2019","unstructured":"Wallace TC. Health effects of coconut oil - a narrative review of current evidence. J Am Coll Nutr. 2019, 38:97-107. 10.1080\/07315724.2018.1497562","journal-title":"J Am Coll Nutr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14537","article-title":"Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics","volume":"20","author":"Nestor MS","year":"2021","unstructured":"Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021, 20:3759-81. 10.1111\/jocd.14537","journal-title":"J Cosmet Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2020.05.006","article-title":"Consensus on the treatment of alopecia areata - Brazilian Society of Dermatology","volume":"95","author":"Ramos PM","year":"2020","unstructured":"Ramos PM, Anzai A, Duque-Estrada B, et al.. Consensus on the treatment of alopecia areata - Brazilian Society of Dermatology. An Bras Dermatol. 2020, 95:39-52. 10.1016\/j.abd.2020.05.006","journal-title":"An Bras Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1995.tb00798.x","article-title":"Allergic contact dermatitis from minoxidil","volume":"32","author":"Ebner H","year":"1995","unstructured":"Ebner H, M\u00fcller E. Allergic contact dermatitis from minoxidil. Contact Dermatitis. 1995, 32:316-7. 10.1111\/j.1600-0536.1995.tb00798.x","journal-title":"Contact Dermatitis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1981.tb135742.x","article-title":"Minoxidil experience in Australia 1974-1980","volume":"1","author":"Jacobs D","year":"1981","unstructured":"Jacobs D, Buttigieg CF. Minoxidil experience in Australia 1974-1980. Med J Aust. 1981, 1:477-8. 10.5694\/j.1326-5377.1981.tb135742.x","journal-title":"Med J Aust"},{"key":"ref23","article-title":"Topical minoxidil: systematic review and meta-analysis of its efficacy in androgenetic alopecia","volume":"13","author":"Gupta AK","year":"2015","unstructured":"Gupta AK, Charrette A. Topical minoxidil: systematic review and meta-analysis of its efficacy in androgenetic alopecia. Skinmed. 2015, 13:185-9.","journal-title":"Skinmed"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2174\/187221312800166859","article-title":"Minoxidil use in dermatology, side effects and recent patents","volume":"6","author":"Rossi A","year":"2012","unstructured":"Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012, 6:130-6. 10.2174\/187221312800166859","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2007.00563.x","article-title":"Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon?","volume":"4","author":"Mondaini N","year":"2007","unstructured":"Mondaini N, Gontero P, Giubilei G, Lombardi G, Cai T, Gavazzi A, Bartoletti R. Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon?. J Sex Med. 2007, 4:1708-12. 10.1111\/j.1743-6109.2007.00563.x","journal-title":"J Sex Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.177432","article-title":"Guidelines on the use of finasteride in androgenetic alopecia","volume":"82","author":"Mysore V","year":"2016","unstructured":"Mysore V, Shashikumar BM. Guidelines on the use of finasteride in androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2016, 82:128-34. 10.4103\/0378-6323.177432","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref27","article-title":"Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic review","volume":"9","author":"Hirshburg JM","year":"2016","unstructured":"Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS. Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic review. J Clin Aesthet Dermatol. 2016, 9:56-62.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1159\/000510697","article-title":"Efficacy of intralesional and oral dutasteride in the treatment of androgenetic alopecia: a systematic review","volume":"6","author":"Herz-Ruelas ME","year":"2020","unstructured":"Herz-Ruelas ME, \u00c1lvarez-Villalobos NA, Mill\u00e1n-Alan\u00eds JM, de Le\u00f3n-Guti\u00e9rrez H, Ocampo-Garza SS, G\u00f3mez-Flores M, Grimalt R. Efficacy of intralesional and oral dutasteride in the treatment of androgenetic alopecia: a systematic review. Skin Appendage Disord. 2020, 6:338-45. 10.1159\/000510697","journal-title":"Skin Appendage Disord"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.17352\/2455-8605.000037","article-title":"A study on the efficacy of microneedling with minoxidil solution versus microneedling with hair multivitamin solution for the treatment of androgenetic alopecia","volume":"6","author":"Neerja P","year":"2020","unstructured":"Neerja P. A study on the efficacy of microneedling with minoxidil solution versus microneedling with hair multivitamin solution for the treatment of androgenetic alopecia. Int J Dermatol Clin Res. 2020, 6:10-2. 10.17352\/2455-8605.000037","journal-title":"Int J Dermatol Clin Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3109\/09546630903578574","article-title":"Hair growth and rejuvenation: an overview","volume":"22","author":"Semalty M","year":"2011","unstructured":"Semalty M, Semalty A, Joshi GP, Rawat MS. Hair growth and rejuvenation: an overview. J Dermatolog Treat. 2011, 22:123-32. 10.3109\/09546630903578574","journal-title":"J Dermatolog Treat"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-013-0021-2","article-title":"Clinical efficacy of a cosmetic treatment by Crescina(\u00ae) human follicle stem cell on healthy males with androgenetic alopecia","volume":"3","author":"Buonocore D","year":"2013","unstructured":"Buonocore D, Nobile V, Michelotti A, Marzatico F. Clinical efficacy of a cosmetic treatment by Crescina(\u00ae) human follicle stem cell on healthy males with androgenetic alopecia. Dermatol Ther (Heidelb). 2013, 3:53-62. 10.1007\/s13555-013-0021-2","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4172\/2471-9323.1000132","article-title":"Efficacy and safety of a new topical hair loss-Lotion containing oleanolic acid, apigenin, biotinyl tripeptide-1, diaminopyrimidine oxide, adenosine, biotin and ginkgo biloba in patients with androgenetic alopecia and telogen effluvium: a six-month open-label prospective clinical study","volume":"4","author":"Garre A","year":"2018","unstructured":"Garre A, Piquero J, Trullas C, et al.. Efficacy and safety of a new topical hair loss-Lotion containing oleanolic acid, apigenin, biotinyl tripeptide-1, diaminopyrimidine oxide, adenosine, biotin and ginkgo biloba in patients with androgenetic alopecia and telogen effluvium: a six-month open-label prospective clinical study. J Cosmo Trichol. 2018, 4:10.4172\/2471-9323.1000132","journal-title":"J Cosmo Trichol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/145558-prospective-efficacy-and-safety-study-of-an-innovative-kerascalp-hair-growth-serum-in-mild-to-moderate-alopecia-in-india-regrowth-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:28Z","timestamp":1707508708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/145558-prospective-efficacy-and-safety-study-of-an-innovative-kerascalp-hair-growth-serum-in-mild-to-moderate-alopecia-in-india-regrowth-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.38742","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,8]]}}}